Intrexon | XON - PE Price to Earnings


Intrexon reported 7.54 in PE Price to Earnings for its fiscal quarter ending in December of 2021.





Pe Change Date
Amgen 25.31 15.82 Dec/2025
Anika Therapeutics 47.54 27.2 Jun/2024
AstraZeneca 27.29 5.8 Dec/2025
Bristol-Myers Squibb 9.28 1.04 Dec/2025
Gilead Sciences 15.63 0.08 Dec/2025
GlaxoSmithKline 11.15 0.29 Dec/2025
Incyte 14.84 2.79 Dec/2025
Intrexon 7.54 221.44 Dec/2021
Ligand Pharmaceuticals 60.65 17.62 Sep/2025
MannKind 303.7 273.14 Dec/2025
Merck 13.92 5.08 Dec/2025
Novartis 17.85 2.11 Dec/2025
Rigel Pharmaceuticals 8.61 8.4 Mar/2025
Roche Holding 16.09 3.51 Dec/2025
Thermo Fisher Scientific 31 6.22 Dec/2025
Veracyte 45.3 5.4 Dec/2025
Xencor 29.92 3.22 Sep/2022